Sponsored Content

SPONSORED CONTENT

For decades, the 340B drug pricing program has served an important purpose by helping hospitals and other covered entities receive discounted prices on drugs to offset care provided to vulnerable, underserved populations.

But over the past several years, drug companies have started pushing back on the 340B program by putting restrictions and conditions in place that have threatened to

SPONSORED CONTENT

In Democracy in America, French sociologist and political theorist Alexis de Tocqueville spoke of the importance of advocacy to American civil society: “In the United States, as soon as several inhabitants have taken an opinion or an idea they wish to promote in society, they seek each other out and unite together once they have made contact. From

SPONSORED CONTENT

As the dispute with drug manufacturers over 340B contract pharmacies drags on, Sentry Data Systems has unveiled a suite of resources and capabilities to help covered entities decide on their next steps. It’s no coincidence that this has happened as Sentry integrates more closely as part of The Craneware Group.

As recent surveys have shown, the manufacturer exclusions on 340B

SPONSORED CONTENT

Hospitals, community health centers and other covered entities participating in the 340B program are not-for-profit and the purpose of 340B is to help them stretch their scarce federal resource dollars to enhance patient care. The mission of covered entities (CEs) participating in this vital program is to provide healthcare services to

SPONSORED CONTENT

Referral prescriptions can be a critical source of 340B savings opportunity for covered entities (CEs) in their mission to “…stretch federal resources as far as possible, reaching more eligible patients and providing more comprehensive services.” Whereas only a few years ago CEs were reluctant to engage in referral prescription opportunities due to compliance concerns,

SPONSORED CONTENT

Are you attending the upcoming 340B Coalition Summer Conference in Washington DC? Join us for Lunch!

Gaylord National Harbor

Monday, August 1 | 11:30 a.m. ET

Join some of the most respected 340B veterans for an interactive panel discussion on the latest updates impacting the 340B program.  Marsha Simon, Ph.D. and William von Oehsen helped to draft the original 340B legislation 30

SPONSORED CONTENT

For 340B covered entities, delivering quality care and providing access to services is critical for the wellbeing of the underserved patient populations in their communities.

When Castle Family Health Centers, a community health center in Merced County California with three locations, sought a partner to support the ongoing performance of their 340B program, their leadership looked for one who shared in the

SPONSORED CONTENT

The 340B drug pricing program enables covered entities to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services. But 340B’s benefit goes beyond providing office visits with a physician and prescriptions to control HIV. 340B also supports the execution of many pharmacy support services. One is AIDS Healthcare Foundation’s Strategic Response Team (SRT). 

Alsean Bryant, an

SPONSORED CONTENT

Community health center (CHC) pharmacies, which have long operated with tight budgets, have recently been further weighed down by a trifecta of woes:

1. Significant staffing shortages and lower margins related to COVID-19 – according to a 2021 Capital Link report, 66% of CHCs risked draining their cash reserves to dangerously low levels and patient visits declined 26%